May 21, 2019
Debiopharm enrolls patient to test treatment in solid tumors
Debiopharm has enrolled first patient in SMARTPLUS-106, a Phase lb/II study in patients failing prior PD-1/PD-L1 treatment in selected solid tumors.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: PD-1/PD-L1